Related Experiment Video
Updated: Sep 27, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
[Detection of serum hepatitis B virus DNA in patients with various chronic liver diseases]
1Department of Gastroenterology, Southwest Hospital, Third Military Medical College, Chongqing 630038.
Insights
Hepatitis B virus (HBV) DNA levels show no significant variation across different chronic liver diseases. Viral replication status in chronic hepatitis B may not solely depend on HBeAg to anti-HBe seroconversion.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Context:
- Chronic liver diseases, including primary hepatic carcinoma, liver cirrhosis, and chronic hepatitis, are often associated with Hepatitis B virus (HBV) infection.
- Assessing HBV DNA concentration and immunological markers is crucial for understanding disease progression and viral activity.
Purpose:
- To determine serum HBV DNA concentration in patients with various chronic liver diseases using a competitive polymerase chain reaction (PCR) method.
- To correlate HBV DNA levels with different serum HBV immunological markers and evaluate the significance of HBeAg to anti-HBe seroconversion.
Summary:
- No significant variation in HBV DNA concentration was observed among patients with primary hepatic carcinoma, liver cirrhosis, and chronic hepatitis.
- Approximately one-third of patients negative for five HBV markers but positive for anti-HBs exhibited low-level viral replication.
- Patients positive for HBeAg had significantly higher HBV DNA concentrations than those positive for anti-HBe, though some anti-HBe positive patients also showed high HBV DNA levels.
Impact:
- The findings suggest that viral replication patterns in chronic HBV infection are not strictly correlated with the duration of the disease.
- HBV replicative status may not be entirely predictable based solely on the seroconversion from HBeAg to anti-HBe.
- This research contributes to a better understanding of HBV dynamics in chronic liver disease patients, potentially influencing diagnostic and therapeutic strategies.
Abstract:
With established competitive polymerase chain reaction (PCR) method, serum HBV DNA concentration was determined in 125 patients with primary hepatic carcinoma(n = 38), liver cirrhosis (n = 36) and chronic hepatitis (n = 51) with different serum HBV immunological markers. The results showed that: (1) No significant variation of HBV DNA concentration was detected in patients with different chronic liver diseases; (2) About one third of the examined patients whose five serum HBV markers were negative and anti-HBs were positive showed low level of viral replications; (3) The total concentration of HBV DNA in the patients with positive HBeAg were significantly higher than that in patients positive for anti-HBe, but also found a high HBV DNA concentration in some of the latter. It suggests that the manner of viral replication were not correlated with the period of the chronic liver disease. So HBV replicative status may not be completely determined only by seroconvertion of HBeAg to anti-HBe.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

